Výsledky vyhledávání - "David Rodbard"

Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy

Autor: David Rodbard

Publikováno v: Diabetes, Obesity and Metabolism. 25:596-601

To evaluate continuous glucose monitoring (CGM) metrics for use as alternatives to glycated haemoglobin (HbA1c) to evaluate therapeutic efficacy.We re-analysed correlations among CGM metrics from studies involving 545 people with type 1 diabetes (T1D

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::933c102f55051ebb86f293ed99c61951
https://doi.org/10.1111/dom.14906

Zobrazit plný text záznamu

Quality of Glycemic Control: Assessment Using Relationships Between Metrics for Safety and Efficacy

Autor: David Rodbard

Publikováno v: Diabetes Technology & Therapeutics. 23:692-704

Numerous methods have been proposed as measures of quality of glycemic control resulting in confusion regarding the best choice of metric to use by clinicians and researchers. Some methods use a single metric such as HbA1c, Mean Glucose, %Time In Ran

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33617683b03dcaeb51650c5fbbc5ad3e
https://doi.org/10.1089/dia.2021.0115

Zobrazit plný text záznamu

Author response for 'CGM Metrics [Mean Glucose, Time Above Range ( % TAR ), and Time In Range ( % TIR )] are superior to HbA1c for assessment of Therapeutic Efficacy'

Autor: null David Rodbard

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::73a22d444f4c02bc6bea37c33c6991d5
https://doi.org/10.1111/dom.14906/v2/response1

Zobrazit plný text záznamu

American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus

Autor: Jeff Unger, David Rodbard, Bruce W. Bode, George Grunberger, Myriam Allende, Thomas Blevins, Richard Hellman, Victor L. Roberts, Yehuda Handelsman, Rosemarie Lajara, Jennifer L. Sherr, Carla Stec

Publikováno v: Endocrine Practice. 27:505-537

Objective To provide evidence-based recommendations regarding the use of advanced technology in the management of persons with diabetes mellitus to clinicians, diabetes-care teams, health care professionals, and other stakeholders. Methods The Americ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::71155ffa22b7a07dc71dd6d1b1b11c9d
https://doi.org/10.1016/j.eprac.2021.04.008

Zobrazit plný text záznamu

Standardizing Reporting of Glucose and Insulin Data for Patients on Multiple Daily Injections Using Connected Insulin Pens and Continuous Glucose Monitoring

Autor: Satish K. Garg, David Rodbard

Publikováno v: Diabetes Technology & Therapeutics. 23:221-226

Background: Recent development and availability of several connected insulin pens with digital memory are likely to expand the availability of glucose and insulin metrics that previously had been available only for the much smaller number of people u

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8786d3b8731c8f57b0d284d77a380109
https://doi.org/10.1089/dia.2021.0030

Zobrazit plný text záznamu

Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID Study

Autor: David Rodbard, Liza L. Ilag, Kelly Ellinor, Ludi Fan, Thomas Blevins, Jennal Johnson, Trang T. Ly, Dana Sindelar, Wendy Lane

Publikováno v: Diabetes Technology & Therapeutics. 23:51-58

Background: The EValuating U-500R Infusion Versus Injection in Type 2 Diabetes Mellitus (VIVID) study compared two methods of U-500R insulin delivery, continuous subcutaneous insulin infusion (CSII...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8befafbb8a78adcca425d4544bf84464
https://doi.org/10.1089/dia.2020.0030

Zobrazit plný text záznamu

Glucose Time In Range, Time Above Range, and Time Below Range Depend on Mean or Median Glucose or HbA1c, Glucose Coefficient of Variation, and Shape of the Glucose Distribution

Autor: David Rodbard

Publikováno v: Diabetes Technology & Therapeutics. 22:492-500

Background: Examine the expected relationships between time in range (%TIR), time above range (%TAR), and time below range (%TBR) with median glucose (or %HbA1c) and %coefficient of variation (%CV)...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0952c9fa152f2a464e79b6e60ab9ab10
https://doi.org/10.1089/dia.2019.0440

Zobrazit plný text záznamu

Biosynthetic Human Insulin and Insulin Analogs

Autor: Helena W Rodbard, David Rodbard

Publikováno v: American Journal of Therapeutics. 27:e42-e51

Background Biosynthetic human insulins and analogs have replaced animal insulins and permitted structural modifications to alter the rate of absorption, duration of action, improve reproducibility of effects, and modulate relative efficacy in various

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ad5af908115b1c5d1f3ab0090284bf95
https://doi.org/10.1097/mjt.0000000000001089

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání